ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1469

A Comparison of Pain and Disability, and Their Association Between Juvenile Primary Fibromyalgia Syndrome and Pediatric Rheumatic Diseases: Results from the Childhood Arthritis and Rheumatology Research Alliance Registry

Jennifer E. Weiss1 and Mark Connelly2, 1Hackensack Univ Med Ctr, Hackensack, NJ, 2Psychology, University of Kansas Medical Center, Kansas City, KS

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: fibromyalgia, functional status, pain, Pediatric rheumatology and quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters. Juvenile Arthritis and Miscellaneous Rheumatic Diseases

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: We aim to determine the extent to which pain severity differs between patients with JPFS and other rheumatic diseases and if the degree of association between pain and functioning is unique to JPFS.

Methods:   We evaluated demographics, pain, functional measures (ACR functional class, current and worst, childhood (C) HAQ, health-related quality of life (HRQoL)) and health status scores from the baseline visits of patients in the CARRA Registry from 5/2010 – 6/2014.  CHAQ assesses activities of daily living; 0 (no disability) to 3 (high disability).  ACR functional class is a 4-point scale indicating patient’s ability to do usual self-care.  HRQoL is a 5-point scale (“excellent” to “very poor”).  Subjective well-being is a 0-10 scale assessing how well patient is doing considering their disease.  General linear models with Dunnett’s post-hoc tests compared JPFS to other diseases on pain and function and Fisher’s r-to-z transformation compared disease groups on the correlation between pain and function.

Results: 9523 patients from infancy to 33 years (M = 12.1, SD = 4.83) (Table 1).  Pain ratings were 1.8±2.6 (Vasculitis) to 6.4±2.4 (JPFS), with pain being significantly higher in the JPFS group (score 6.4/10) than any other group (effect sizes = .22 to 1.05).  Ratings on disability measures were significantly worse for JPFS patients (effect sizes = .62 to 1.06) regardless of physician-rated disease severity (Fig. 1).  However, the relationship between pain severity and function/disability was in most cases significantly greater for rheumatic disease patients relative to JPFS and was highest among dermatomyositis, JIA, and MCTD patients (Fig. 2). 

Conclusion: JPFS is unique with regard to the perceived severity of pain and disability, yet pain appears to be comparably or more highly associated with disability in other rheumatic diseases. Given the association of pain severity with functional ability across most rheumatic diseases, regardless of disease severity, pain needs further research and increased prioritization in treatment.

Table 1. Demographic data for JPFS and disease cohorts

Variable

JPFS Cohort

(n = 180)

Rheumatic Disease Cohort

(n = 9343)

Age (years)

9-21 (M = 15.4, SD = 2.2)

0-33 (M = 4.0, SD = 4.8)

Sex

85% female

73% female

Race

86% White

6% Black/AA

8% Other

81% White

9% Black/AA

10% Other

Ethnicity

16% Hispanic

13% Hispanic

Median income

$75-$100,000

$50-$75,000

Disease type

   JIA

   SLE

   Dermatomyositis

   Localizing scleroderma

   CNS vasculitis

   MCTD

   Uveitis

   Autoinflammatory disorders

   Systemic sclerosis

   Sarcoidosis

   Sjögren’s syndrome

Unknown

6538 (69.0%)

1004 (11.0%)

632 (7.0%)

390 (4.1%)

192 (2.0%)

139 (1.5%)

103(1.1%)

92 (1.0%)

61 (0.6%)

49 (0.5%)

27 (0.3%)

116 (1.2%)

Figure 1.  Functional measures as a function of disease

Figure 2.  Correlation coefficients (Spearman rho) for the association of pain and function across disease cohorts (higher values = greater association)


Disclosure: J. E. Weiss, None; M. Connelly, None.

To cite this abstract in AMA style:

Weiss JE, Connelly M. A Comparison of Pain and Disability, and Their Association Between Juvenile Primary Fibromyalgia Syndrome and Pediatric Rheumatic Diseases: Results from the Childhood Arthritis and Rheumatology Research Alliance Registry [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/a-comparison-of-pain-and-disability-and-their-association-between-juvenile-primary-fibromyalgia-syndrome-and-pediatric-rheumatic-diseases-results-from-the-childhood-arthritis-and-rheumatology/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-comparison-of-pain-and-disability-and-their-association-between-juvenile-primary-fibromyalgia-syndrome-and-pediatric-rheumatic-diseases-results-from-the-childhood-arthritis-and-rheumatology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology